Walker Christopher J, Cowan David A, James Vivian H T, Lau Joanne C Y, Kicman Andrew T
King's College London, Drug Control Centre, Pharmaceutical Science Research Division, Franklin-Wilkins Building, 150 Stamford Street, London SE1 9NH, United Kingdom.
Steroids. 2009 Mar;74(3):335-40. doi: 10.1016/j.steroids.2008.10.006. Epub 2008 Nov 1.
The finding of measurable amounts of 19-norandrostenedione in norethisterone tablets prompted us to develop an assay to quantify this steroid. 19-Norandrostenedione is an anabolic steroid whose use in sport is prohibited by the World Anti-Doping Agency (WADA). The assay was developed using isotope dilution and liquid chromatography-tandem mass spectrometry (LC-MS/MS) for the quantification of 19-norandrostenedione in norethisterone formulations, with [3,4-(13)C(2)]-19-norandrostenedione as the internal standard. The results showed amounts up to 1.01+/-0.01microg (mean+/-S.E.M.) per tablet in those containing 5mg of norethisterone or norethisterone acetate (0.02%, w/w) and up to 0.5+/-0.01microg (mean+/-S.E.M.) per tablet (0.05%, w/w) in oral contraceptive tablets containing 0.35-1.5mg of norethisterone or norethisterone acetate. No tablet tested exceeded the British Pharmacopoeia limit of 0.1% for this impurity.
在炔诺酮片中发现可测量量的19-去甲雄烯二酮促使我们开发一种测定该类固醇的方法。19-去甲雄烯二酮是一种合成代谢类固醇,世界反兴奋剂机构(WADA)禁止其在体育运动中使用。该测定方法采用同位素稀释和液相色谱-串联质谱法(LC-MS/MS),以[3,4-(13)C(2)]-19-去甲雄烯二酮为内标,用于定量炔诺酮制剂中的19-去甲雄烯二酮。结果显示,每片含5mg炔诺酮或醋酸炔诺酮的片剂中含量高达1.01±0.01μg(平均值±标准误)(0.02%,w/w),而每片含0.35-1.5mg炔诺酮或醋酸炔诺酮的口服避孕药片中含量高达0.5±0.01μg(平均值±标准误)(0.05%,w/w)。所测试的片剂中没有一种超过英国药典规定的该杂质0.1%的限度。